Patent · US Active

Compound having ERK kinase inhibitory activity and use thereof

US11465984B2 · kind B2 · utility

0Cited by

0References

25Claims

0Family size

Assignees

Inventors

Lei Li · Zhengzhou, CN
Meiyu Geng · Shanghai, CN
Ying-Huey Huang · Taipei, TW
Jian Ding · Shanghai, CN
Qiong Zhang · Plano, US
Min Huang · Chongqing, CN
Shuai Tang · Ibaraki, JP
Ning Shen · Cambridge, US
Yi Chen · Shanghai, CN

Key dates

Filing date	Sep 29, 2018
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Sep 29, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I): wherein variables are as defined in the specification. The compound is an inhibitor of an ERK kinase, e.g. ERK1 and/or ERK2 kinase. The invention also relates to the use of the compound and a method for preparing the compound, and a pharmaceutical composition containing the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.